Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damian A Laber

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Medical Oncology (Northwood, London, England)|February 17, 2007
Risk factors, classification, and staging of renal cell cancerDamian A Laber
Cancer Investigation|July 1, 2006
Why did he die?Damian A Laber
The Journal of the Kentucky Medical Association|May 8, 2009
Bladder cancer: clinical practiceGuilherme Rabinowits, Damian A Laber
Cureus|August 2, 2023
Anticoagulation With Platelet Transfusions for Acute Limb Ischemia With Severe ThrombocytopeniaKhalid Shakfeh, Damian A Laber
Clinical Genitourinary Cancer|February 14, 2009
Compassionate use of sorafenib in patients with advanced renal cell cancerDamian A Laber, Mian Mushtaq
Southern Medical Journal|June 28, 2006
Ceftriaxone-resistant Salmonella septicemia and osteomyelitis in sickle cell disease adultsJames S Morgan, Damian A Laber
American Journal of Hematology|February 24, 2006
Cefotetan-induced hemolytic anemia after perioperative prophylaxisMonte E Martin, Damian A Laber
European Journal of Haematology|July 8, 2005
Etiology of thrombocytopenia in all patients treated with heparin productsDamian A Laber, Monte E Martin
American Journal of Hematology|April 29, 2004
Clinical spectrum of myelophthisis in cancer patientsStephen N Makoni, Damian A Laber
Anticancer Research|September 6, 2017
Metastatic Microcystic Adnexal Carcinoma with DNA Sequencing Results and Response to Systemic Antineoplastic ChemotherapyMin-Bin Chen, Damian A Laber
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Medical Oncology (Northwood, London, England)|February 17, 2007
Risk factors, classification, and staging of renal cell cancerDamian A Laber
Cancer Investigation|July 1, 2006
Why did he die?Damian A Laber
The Journal of the Kentucky Medical Association|May 8, 2009
Bladder cancer: clinical practiceGuilherme Rabinowits, Damian A Laber
Cureus|August 2, 2023
Anticoagulation With Platelet Transfusions for Acute Limb Ischemia With Severe ThrombocytopeniaKhalid Shakfeh, Damian A Laber
Clinical Genitourinary Cancer|February 14, 2009
Compassionate use of sorafenib in patients with advanced renal cell cancerDamian A Laber, Mian Mushtaq
Southern Medical Journal|June 28, 2006
Ceftriaxone-resistant Salmonella septicemia and osteomyelitis in sickle cell disease adultsJames S Morgan, Damian A Laber
American Journal of Hematology|February 24, 2006
Cefotetan-induced hemolytic anemia after perioperative prophylaxisMonte E Martin, Damian A Laber
European Journal of Haematology|July 8, 2005
Etiology of thrombocytopenia in all patients treated with heparin productsDamian A Laber, Monte E Martin
American Journal of Hematology|April 29, 2004
Clinical spectrum of myelophthisis in cancer patientsStephen N Makoni, Damian A Laber
Anticancer Research|September 6, 2017
Metastatic Microcystic Adnexal Carcinoma with DNA Sequencing Results and Response to Systemic Antineoplastic ChemotherapyMin-Bin Chen, Damian A Laber
Pageof 5